{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:26:05Z","timestamp":1649154365596},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6327","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T19:02:52Z","timestamp":1467313372000},"page":"1807-1810","source":"Crossref","is-referenced-by-count":0,"title":["Persistent Infection of Drug-resistant Influenza A Virus during Chemotherapy for Malignant Lymphoma"],"prefix":"10.2169","volume":"55","author":[{"given":"Toru","family":"Kawakami","sequence":"first","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"},{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hirabayashi","sequence":"additional","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Isobe","sequence":"additional","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Mimura","sequence":"additional","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Furuta","sequence":"additional","affiliation":[{"name":"Internal Medicine, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Shimazaki","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Nagano Environmental Conservation Research Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Kitano","sequence":"additional","affiliation":[{"name":"Division of Hematology, NHO Matsumoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167: 775-785, 2008.","DOI":"10.1093\/aje\/kwm375"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bruminhent J, Deziel PJ, Wotton JT, Binnicker MJ, Razonable RR. Prolonged shedding of pandemic influenza A (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient. J Clin Virol 61: 302-304, 2014.","DOI":"10.1016\/j.jcv.2014.07.004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 28: 1071-1076, 2007.","DOI":"10.1086\/520101"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 200: 492-500, 2009.","DOI":"10.1086\/600383"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Klimov AI, Rocha E, Hayden FG, et al. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 172: 1352-1355, 1995.","DOI":"10.1093\/infdis\/172.5.1352"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 26: 1418-1424, 1998.","DOI":"10.1086\/516358"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of amantadine-resistant influenza A virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clin Infect Dis 34: E23-E25, 2002.","DOI":"10.1086\/338870"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39: 1300-1306, 2004.","DOI":"10.1086\/425004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Memoli MJ, Athota R, Reed S, et al. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 58: 214-224, 2014.","DOI":"10.1093\/cid\/cit725"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 193: 760-764, 2006.","DOI":"10.1086\/500465"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 178: 1257-1262, 1998.","DOI":"10.1086\/314440"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Abed Y, Baz M, Boivin G. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A\/H3N2 virus. J Infect Dis 199: 180-183, 2009.","DOI":"10.1086\/595736"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Memoli MJ, Hrabal RJ, Hassantoufighi A, et al. Rapid selection of a transmissible multidrug-resistant influenza A\/H3N2 virus in an immunocompromised host. J Infect Dis 201: 1397-1403, 2010.","DOI":"10.1086\/651610"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ant\u00f3n A, L\u00f3pez-Iglesias AA, T\u00f3rtola T, et al. Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors. Diagn Microbiol Infect Dis 68: 214-219, 2010.","DOI":"10.1016\/j.diagmicrobio.2010.08.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. van der Vries E, Stittelaar KJ, van Amerongen G, et al. Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog 9: e1003343, 2013.","DOI":"10.1371\/journal.ppat.1003343"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. van der Vries E, Stelma FF, Boucher CA. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med 363: 1381-1382, 2010.","DOI":"10.1056\/NEJMc1003749"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nguyen HT, Fry AM, Gubareva LV. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antivir Ther 17: 159-173, 2012.","DOI":"10.3851\/IMP2067"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takashita E, Fujisaki S, Kishida N, et al. Characterization of neuraminidase inhibitor-resistant influenza A (H1N1) pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan. Influenza Other Respir Viruses 7: 1390-1399, 2013.","DOI":"10.1111\/irv.12132"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takashita E, Meijer A, Lackenby A, et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. Antiviral Res 117: 27-38, 2015.","DOI":"10.1016\/j.antiviral.2015.02.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Meijer A, Rebelo-de-Andrade H, Correia V, et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013. Antiviral Res 110: 31-41, 2014.","DOI":"10.1016\/j.antiviral.2014.07.001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ong AK, Hayden FG. John F. Enders lecture 2006: antivirals for influenza. J Infect Dis 196: 181, 2007.","DOI":"10.1086\/518939"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Moscona A, McKimm-Breschkin J. News about influenza B drug resistance that cannot be ignored. JAMA 297: 1492-1493, 2007.","DOI":"10.1001\/jama.297.13.1492"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Z\u00fcrcher T, Yates PJ, Daly J, et al. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. J Antimicrob Chemother 58: 723-732, 2006.","DOI":"10.1093\/jac\/dkl321"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ives JA, Carr JA, Mendel DB, et al. The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55: 307-317, 2002.","DOI":"10.1016\/S0166-3542(02)00053-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Herlocher ML, Truscon R, Elias S, et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 190: 1627-1630, 2004.","DOI":"10.1086\/424572"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/13\/55_55.6327\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:33:39Z","timestamp":1498311219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/13\/55_55.6327\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6327","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}